Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
about
Linking proteins to signaling pathways for experiment design and evaluationCharacterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments.Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner.Discovery and preclinical validation of drug indications using compendia of public gene expression data.The influence of cis-regulatory elements on DNA methylation fidelity.EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerTWIST and ovarian cancer stem cells: implications for chemoresistance and metastasisCombined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthCOL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilizationIdentifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissuesThe RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatmentWnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancerGap junctions and connexins as therapeutic targets in cancer.The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.In vivo gene expression profiling for chemosensitivity to docetaxel-cisplatin-5-FU (TPF) triplet regimen in laryngeal squamous cell carcinoma and the effect of TPF treatment on related gene expression in vitro.The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Adenovirus type 12 E1B 55-kilodalton oncoprotein promotes p53-mediated apoptotic response of ovarian cancer to cisplatin.Comparative analyses of cytotoxicity and molecular mechanisms between platinum metallointercalators and cisplatin.BRCA1-mediated signaling pathways in ovarian carcinogenesis.Alterations in gene expression profiles correlated with cisplatin cytotoxicity in the glioma U343 cell line.Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells.Bioinformatics Approaches to Predict Drug Responses from Genomic Sequencing.Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.Relevance of Copper and Organic Cation Transporters in the Activity and Transport Mechanisms of an Anticancer Cyclometallated Gold(III) Compound in Comparison to Cisplatin
P2860
Q28482688-E5565518-F079-41DF-9913-3770E8F3DB60Q33645678-E67E094C-86FC-4A34-8D80-30CE1569D4CDQ33750182-62DF2FCF-2470-4F00-B51A-B0006E43F14CQ33930946-973B0020-03AA-4BCA-B4E9-9BEB9950418DQ33995422-B424EA72-AEC0-4FC0-81E7-A727ECE86DF9Q34193554-BB236049-BE6A-4AB4-A328-FA16EBCB21ECQ34202046-5ED35A17-3FB1-4701-B5DA-41575CC4E550Q34365639-2136558A-05EB-491C-93E7-AB80E4DB4A39Q35944751-0366B3A2-B1BF-406C-9E3B-845A31869993Q36011433-B5B3588D-AEAD-4214-8388-4354524138B1Q36414284-A03AD25E-7D8F-4A76-9068-A5CECFF28408Q36562337-BF520AF7-1F8D-4078-B8F7-9EF31AA1E339Q36798094-2FD2928C-A600-499F-B846-6820E3D68022Q36931470-83688A6B-A390-43B9-857B-A809F276CD2DQ37035513-910F4D6F-CE64-4031-9BC8-62B4D6014025Q37589190-6A88E17C-1E08-4F47-9644-0565507ED92FQ37743527-A26B5C96-4D20-4748-B36C-6F5CDD0BC743Q38291073-2A707110-2C1B-4D11-8B76-8A2081C188ADQ38437713-D7E266EA-7686-4A42-BB26-BCB11F0B4198Q38654867-CA72E3BE-7FE1-4E2F-8264-9F639FFF745CQ38893456-2509DF0B-F70B-4AEE-9C6F-FC0749542660Q39311584-3349846C-F61C-45AF-9A1E-183207290BD3Q39480429-80F14405-48A7-43C6-A772-87DFB945F0DAQ39757559-CF52B66E-374E-4516-A3BC-E71196D3F414Q39914343-8B705BD9-CB94-4F32-9EE1-522DBE45B1D0Q47691219-062980C0-51A7-4636-AA54-10C9CE126A22Q47726158-5A28BA1F-BF60-4083-A985-03DCC298EFEEQ47942760-CF609D9F-562D-46DD-B3D3-4B5AEE7B6C1BQ58764839-8D180359-2E5C-47A9-B4A2-87532A6E5D28
P2860
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gene expression response to ci ...... esistant ovarian cancer cells.
@en
type
label
Gene expression response to ci ...... esistant ovarian cancer cells.
@en
prefLabel
Gene expression response to ci ...... esistant ovarian cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Gene expression response to ci ...... esistant ovarian cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210086
P407
P577
2006-10-30T00:00:00Z
P5875
P6179
1017065605